230 related articles for article (PubMed ID: 19603000)
1. Influence of coagulation factor x on in vitro and in vivo gene delivery by adenovirus (Ad) 5, Ad35, and chimeric Ad5/Ad35 vectors.
Greig JA; Buckley SM; Waddington SN; Parker AL; Bhella D; Pink R; Rahim AA; Morita T; Nicklin SA; McVey JH; Baker AH
Mol Ther; 2009 Oct; 17(10):1683-91. PubMed ID: 19603000
[TBL] [Abstract][Full Text] [Related]
2. Pseudotyping the adenovirus serotype 5 capsid with both the fibre and penton of serotype 35 enhances vascular smooth muscle cell transduction.
Parker AL; White KM; Lavery CA; Custers J; Waddington SN; Baker AH
Gene Ther; 2013 Dec; 20(12):1158-64. PubMed ID: 24005577
[TBL] [Abstract][Full Text] [Related]
3. Biodistribution and retargeting of FX-binding ablated adenovirus serotype 5 vectors.
Alba R; Bradshaw AC; Coughlan L; Denby L; McDonald RA; Waddington SN; Buckley SM; Greig JA; Parker AL; Miller AM; Wang H; Lieber A; van Rooijen N; McVey JH; Nicklin SA; Baker AH
Blood; 2010 Oct; 116(15):2656-64. PubMed ID: 20610817
[TBL] [Abstract][Full Text] [Related]
4. Identification of coagulation factor (F)X binding sites on the adenovirus serotype 5 hexon: effect of mutagenesis on FX interactions and gene transfer.
Alba R; Bradshaw AC; Parker AL; Bhella D; Waddington SN; Nicklin SA; van Rooijen N; Custers J; Goudsmit J; Barouch DH; McVey JH; Baker AH
Blood; 2009 Jul; 114(5):965-71. PubMed ID: 19429866
[TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo properties of adenovirus vectors with increased affinity to CD46.
Wang H; Liu Y; Li Z; Tuve S; Stone D; Kalyushniy O; Shayakhmetov D; Verlinde CL; Stehle T; McVey J; Baker A; Peng KW; Roffler S; Lieber A
J Virol; 2008 Nov; 82(21):10567-79. PubMed ID: 18753195
[TBL] [Abstract][Full Text] [Related]
6. [Characterization of adenovirus serotype 35 vectors using genetically modified animals and non-human primates].
Sakurai F; Kawabata K; Mizuguchi H
Yakugaku Zasshi; 2006 Nov; 126(11):1013-9. PubMed ID: 17077607
[TBL] [Abstract][Full Text] [Related]
7. Adenovirus serotype 35 vector-induced innate immune responses in dendritic cells derived from wild-type and human CD46-transgenic mice: Comparison with a fiber-substituted Ad vector containing fiber proteins of Ad serotype 35.
Sakurai F; Nakashima K; Yamaguchi T; Ichinose T; Kawabata K; Hayakawa T; Mizuguchi H
J Control Release; 2010 Dec; 148(2):212-8. PubMed ID: 20800630
[TBL] [Abstract][Full Text] [Related]
8. Transduction of liver metastases after intravenous injection of Ad5/35 or Ad35 vectors with and without factor X-binding protein pretreatment.
Liu Y; Wang H; Yumul R; Gao W; Gambotto A; Morita T; Baker A; Shayakhmetov D; Lieber A
Hum Gene Ther; 2009 Jun; 20(6):621-9. PubMed ID: 19245296
[TBL] [Abstract][Full Text] [Related]
9. Adenovirus serotype 35 vector-mediated transduction into human CD46-transgenic mice.
Sakurai F; Kawabata K; Koizumi N; Inoue N; Okabe M; Yamaguchi T; Hayakawa T; Mizuguchi H
Gene Ther; 2006 Jul; 13(14):1118-26. PubMed ID: 16541121
[TBL] [Abstract][Full Text] [Related]
10. Cell entry and trafficking of human adenovirus bound to blood factor X is determined by the fiber serotype and not hexon:heparan sulfate interaction.
Corjon S; Gonzalez G; Henning P; Grichine A; Lindholm L; Boulanger P; Fender P; Hong SS
PLoS One; 2011; 6(5):e18205. PubMed ID: 21637339
[TBL] [Abstract][Full Text] [Related]
11. Development and evaluation of a novel gene delivery vehicle composed of adenovirus serotype 35.
Sakurai F
Biol Pharm Bull; 2008 Oct; 31(10):1819-25. PubMed ID: 18827334
[TBL] [Abstract][Full Text] [Related]
12. Blood Coagulation Factor X Exerts Differential Effects on Adenovirus Entry into Human Lymphocytes.
Findlay JS; Cook GP; Blair GE
Viruses; 2018 Jan; 10(1):. PubMed ID: 29301346
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of CD46 re-targeted adenoviral vectors for clinical ovarian cancer intraperitoneal therapy.
Hulin-Curtis SL; Uusi-Kerttula H; Jones R; Hanna L; Chester JD; Parker AL
Cancer Gene Ther; 2016 Jul; 23(7):229-34. PubMed ID: 27229159
[TBL] [Abstract][Full Text] [Related]
14. Development of adenovirus serotype 35 as a gene transfer vector.
Seshidhar Reddy P; Ganesh S; Limbach MP; Brann T; Pinkstaff A; Kaloss M; Kaleko M; Connelly S
Virology; 2003 Jul; 311(2):384-93. PubMed ID: 12842627
[TBL] [Abstract][Full Text] [Related]
15. Efficient gene delivery in human and rodent mast cells using adenovirus vectors.
Nakashima K; Sakurai F; Kawabata K; Mizuguchi H
J Control Release; 2008 Aug; 129(3):215-22. PubMed ID: 18572269
[TBL] [Abstract][Full Text] [Related]
16. Manipulating adenovirus hexon hypervariable loops dictates immune neutralisation and coagulation factor X-dependent cell interaction in vitro and in vivo.
Ma J; Duffy MR; Deng L; Dakin RS; Uil T; Custers J; Kelly SM; McVey JH; Nicklin SA; Baker AH
PLoS Pathog; 2015 Feb; 11(2):e1004673. PubMed ID: 25658827
[TBL] [Abstract][Full Text] [Related]
17. [Development of a replication-incompetent adenovirus vector derived from subgroup B adenovirus serotype 35].
Sakurai F
Yakugaku Zasshi; 2008 Dec; 128(12):1751-61. PubMed ID: 19043294
[TBL] [Abstract][Full Text] [Related]
18. Characterization of in vitro and in vivo gene transfer properties of adenovirus serotype 35 vector.
Sakurai F; Mizuguchi H; Yamaguchi T; Hayakawa T
Mol Ther; 2003 Nov; 8(5):813-21. PubMed ID: 14599815
[TBL] [Abstract][Full Text] [Related]
19. Coagulation factor X mediates adenovirus type 5 liver gene transfer in non-human primates (Microcebus murinus).
Alba R; Bradshaw AC; Mestre-Francés N; Verdier JM; Henaff D; Baker AH
Gene Ther; 2012 Jan; 19(1):109-13. PubMed ID: 21677690
[TBL] [Abstract][Full Text] [Related]
20. Substitution of adenovirus serotype 3 hexon onto a serotype 5 oncolytic adenovirus reduces factor X binding, decreases liver tropism, and improves antitumor efficacy.
Short JJ; Rivera AA; Wu H; Walter MR; Yamamoto M; Mathis JM; Curiel DT
Mol Cancer Ther; 2010 Sep; 9(9):2536-44. PubMed ID: 20736345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
